Moscow, July 17, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the «Company») announces that pursuant to the Company’s buyback program, announced on February 15, 2013 (further the «Program»), 15 009 162 GDRs and 140 000 ordinary shares were purchased on the open market as of July 16, 2013. All purchases of GDRs were made by an independent broker Citigroup Global Markets Limited for the account of Pharmstandard-Leksredstva OJSC, an indirect wholly owned subsidiary of the Company.
Therefore, since the start of Pharmstandard’s buyback program the following securities have been purchased:
|
Date |
Type |
Amount (shares) |
Price per share |
Amount |
|
USD |
RUR |
USD |
RUR |
|
22/04/13 |
GDR |
220 000 |
20,4659 |
643,87 |
4 502 498,00 |
141 650 838,33 |
|
26/04/13 |
GDR |
3 056 305 |
20,4000 |
638,86 |
62 348 622,00 |
1 952 565 560,31 |
|
20/06/13 |
ORDS |
140 000 |
65,4082 |
2 150,00 |
9 157 148,00 |
301 000 000,00 |
|
26/06/13 |
GDR |
1 718 574 |
20,3500 |
665,73 |
34 972 980,90 |
1 144 106 097,16 |
|
26/06/13 |
GDR |
115 421 |
20,5500 |
672,27 |
2 371 901,55 |
77 594 387,31 |
|
09/07/13 |
GDR |
364 000 |
16,8500 |
561,46 |
6 133 400,00 |
204 371 021,40 |
|
10/07/13 |
GDR |
2 833 075 |
15,8500 |
528,14 |
44 904 238,75 |
1 496 254 139,39 |
|
11/07/13 |
GDR |
3 000 000 |
11,9000 |
387,78 |
35 700 000,00 |
1 163 345 190,00 |
|
12/07/13 |
GDR |
1 100 000 |
10,9500 |
356,82 |
12 045 000,00 |
392 506 801,50 |
|
15/07/13 |
GDR |
410 000 |
12,9000 |
421,09 |
5 289 000,00 |
172 648 298,10 |
|
16/07/13 |
GDR |
2 191 787 |
13,6000 |
443,66 |
29 808 303,20 |
972 406 466,99 |
|
Total : |
|
15 149 162 |
|
|
247 233 092,40 |
8 018 448 800,49 |
The last buy-back took place on July 16: 2 191 787 GDRs at the price of 13,60 USD per GDR.
The Program was approved in respect of ordinary shares of Pharmstandard OJSC and/or Global Depositary Receipts representing Shares (each Share representing 4 GDRs) in the aggregate amount of up to RUR8 billion. Duration of program: December 31, 2013.
The total sum of securities purchased as of July 16, 2013 constitutes RUR 8 018 448 800,49, hence, the Programs may be considered as completed.
New shareholder structure is as follows:
Augment Investments Limited – 54,3185% (ordinary shares and GDRs)
LSE – 17,64% (GDRs)
RTS/MICEX – 9,31% (ordinary shares)
Pharmstandard-Leksredstva OJSC – 18,7392% % (ordinary shares and GDRs)
Regards,
Irina Bakhturina
Investor Relations
Pharmstandard OJSC
Tel. (495) 970-0030 ext.2824
Fax (495) 970-0032
www.pharmstd.ru
|
